Advanced Search | View Cart | Check Out | 800.633.4743
Bookmark and Share

Congress of Clinical Rheumatology

Directed by David Andrew McLain, MD, FACP, FACR
McLAIN MEDICAL ASSOCIATES, P.C.

The Congress of Clinical Rheumatology is a comprehensive program with an international perspective designed for clinical rheumatologists to emphasize pertinent, emerging issues, and cutting edge advancements in rheumatology that can be directly implemented in practice to improve patient care. Learn from the best in the comfort of your home or office. This self-paced activity is now available on multimedia formats to fit your schedule and preparation preference. What’s more, it will include a detailed syllabus on CD-ROM that features enlargeable full-color images of each slide from all the presentations.


 
CREDITS Earn up to 23 AMA PRA Category 1 Credits
CE RELEASE January 15, 2015
CE EXPIRE January 15, 2018
ONLINE PRICE $795.00
(You will be redirected to Oakstone.com)
 

Description


This program is intended for Clinical Rheumatologists and other physicians who are directly involved in the care and management of rheumatic disease patients. The emphasis of this course is on cutting edge advancements and pertinent, emerging issues in clinical rheumatology.
 
 

Intended Audience


Although intended primarily for clinical rheumatologists, the Congress of Clinical Rheumatology is also of great interest and value to physicians or other health care personnel who are directly involved in the care and management of rheumatic disease patients.
 
 

Topics & Speakers


  • Behçet's Syndrome: Update 2014
    Yusuf Yazici, MD

  • Lupus Update 2014
  • Antiphospholipid Antibody Syndrome Update
    Michelle Petri, MD, MPH

  • Scleroderma - Evidence of a Vascular Disease
  • Vascular Treat to Target - Possible Strategy
    in Scleroderma?

    Fredrick Wigley, MD

  • Infections and Autoimmunity – How Can We Harness Nature to Treat Autoimmune Diseases?
  • ASIA: Autoimmune/Autoinflammatory Syndrome – Induced by Adjuvants and Autoimmune Rheumatic Diseases, 2014
  • To D or Not to D? - This is the Question
    Yehuda Shoenfeld, MD, FRCP

  • Central Pain Mechanisms in the Rheumatic Diseases
    Kristine Phillips, MD, PhD

  • Connective Tissue Disease and Dermatology: Cutaneous Lupus, Dermatomyositis and Scleroderma
  • Clinical Cases in Rheumatology-Dermatology
    Ruth Ann Vleugels, MD, MPH

  • Cryoglobulinemia
    Peter Gorevic, MD

  • Inclusion Body Myositis
    Thomas Lloyd, MD, PhD

  • CCR Thieves' Market
    Alan Epstein, MD, Moderator

  • Joint Hypermobility Syndrome - An Evolving
    Multi-System Disorder
  • Management of the Joint Hypermobility Syndrome
    Rodney Grahame, CBE, MD, FRCP, FACP

  • Gout Update
  • Inflammatory Eye Diseases in the Rheumatic
    Disease Patient

    Robert Keenan, MD, MPH

  • What's New in Spinal Osteoarthritis?
    Alfred C. Gellhorn, MD

  • Disease Activity Measurement and Biomarkers in RA
    Max Hamburger, MD

  • Current Legislative & Regulatory Issues Facing Rheumatologists
    Robert S. Jasak, JD

  • Sequential/Combination Therapy in Osteoporosis
  • Treatment to Goal in Osteoporosis
    Felicia Cosman, MD

  • Regulation of Bone Homeostasis: Signaling Pathways and Novel Targets
    David W. Dempster, PhD, FRMS

 
 

Faculty


Felicia Cosman, MD
Professor of Medicine
Columbia University College of Physicians & Surgeons 
Helen Hayes Hospital
West Haverstraw, NY

David W. Dempster, PhD, FRMS       
Professor of Clinical Pathology & Cell Biology
College of Physicians & Surgeons
Columbia University, NY
Director Emeritus, Regional Bone Center
Helen Hayes Hospital
New York State Department of Health

Alan Epstein, MD
Associate Professor of Medicine
Division of Rheumatology
University of Pennsylvania School of Medicine
Philadelphia, PA   

Alfred Gellhorn, MD
Clinical Assistant Professor
Department of Rehabilitation Medicine
University of Washington School of Medicine
Seattle, WA  
 

Peter Gorevic, MD  
Professor of Medicine
Mount Sinai School of Medicine
New York, NY 

Rodney Grahame, CBE, MD, FRCP, FACP
Honorary Professor
Center for Rheumatology
University College London Hospitals
London, England

Max Hamburger, MD 
Managing Partner, Rheumatology Associates of Long Island
Assistant Professor of Clinical Medicine, SUNY Stony Brook
President, New York State Rheumatology Society
President, American Society of Clinical Rheumatologists
Melville, NY  

Robert S. Jasak, JD
Vice President
Coverage & Payment Policy
Hart Health Strategies
Washington, DC

Robert Keenan MD, MPH
Assistant Professor of Medicine
Duke University School of Medicine
Durham, NC

Kristine Phillips, MD, PhD            
Associate Professor
Division of Rheumatology
University of Michigan Medical School
Ann Arbor, MI 

Thomas Lloyd MD, PhD
Assistant Professor
Department of Neurology and Neuroscience
Johns Hopkins University School of Medicine
Baltimore, MD  
  

Michelle Petri, MD, MPH     
Professor of Medicine
Director, Lupus Center
Johns Hopkins University School of Medicine
Baltimore, MD
 

Yehuda Shoenfeld, MD, FRCP
Head, Zabludowicz Center for Autoimmune Diseases
Incumbent of Laura Schwartz-Kipp Research Chair in
Autoimmune Diseases
Tel Aviv University Sackler Faculty of Medicine
Tel-Hashomer, Israel

Ruth Ann Vleugels, MD, MPH
Assistant Professor of Dermatology
Harvard Medical School
Director, Autoimmune Skin Disease Program
Brigham & Women's Hospital
Boston, MA

Fredrick Wigley, MD
Professor of Medicine
Associate Director, Division of Rheumatology
Director, Johns Hopkins Scleroderma Center 
Johns Hopkins University School of Medicine
Baltimore, MD 
    

Yusuf Yazici, MD
Assistant Professor
Director, Seligman Center for Advanced Therapeutics &
Behçet's Syndrome Center
New York University School of Medicine
New York, NY 
                              


 
 

Learning Objectives


After viewing this program, participants will be better able to:
  • Discuss the reasons why Mixed Connective Tissue Disease is not really mixed.
  • Predict brain changes in the first month of daily opioid therapy and review implications for addiction and hyperalgesia.
  • Evaluate the evidence and discussions that were used to generate the ACR treatment guidelines for lupus nephritis and assess new SLE therapies.
  • Identify the features of IgG4-related disease.
  • Assess mechanisms and prevention approaches for accelerated atherosclerosis in SLE.
  • Describe the current state of the art treatment of ANCA--associated vasculitis.
  • Define new mechanisms involved in the development of osteoarthritis.
  • Illustrate the complex relationship between chronic kidney disease and bone disease in adults.
  • Summarize the current concepts of low dose naltrexone in the treatment of fibromyalgia.
  • Name the advances in the pathogenesis and treatment of sarcoidosis.
  • Evaluate the latest research on the effect of arthritis on bone and cartilage.
  • Appraise imaging of the immune system.
  • List the legislative and regulatory issues facing rheumatologists.
  • Formulate a treatment plan for scleroderma manifestations.
  • Assess complementary and alternative medicine as it applies to rheumatology.
  • Identify the clinical rheumatology questions that have been answered in the laboratory.
  • List the therapeutic options available for psoriatic arthritis.
  • Recall the latest data on myopathies from pathogeny to treatment.
  • Summarize the news on bone erosion in rheumatoid arthritis.
  • Discuss the latest research on interstitial lung disease.
  • Identify the rheumatic manifestations of cancer.
  • Describe unusual rheumatology cases and unusual presentations of common rheumatologic conditions as presented in the thieves’ market.
  • Assess the translational science journey that was involved with glucocorticoid--induced osteoporosis.
  • Compare combination treatment regimens in osteoporosis.

 
 

Accreditation Statement


This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Oakstone Publishing, LLC and A&R Education Group LLC. Oakstone Publishing, LLC is accredited by the ACCME to provide continuing medical education for physicians.
 
 

Designation


Oakstone Publishing, LLC, designates this enduring material for a maximum of 23 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Date of Original Release: January 15,  2015
Date Credits Expire: January 15, 2018
Estimated Time to Complete: 23 hours

CME credit is awarded upon successful completion of a course evaluation and post-test.